| An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. CK Desai, G Iyer, J Panchal, S Shah, RK Dikshit Perspectives in clinical research 2 (4), 2011 | 243 | 2011 |
| Cardiovascular risks of exogenous testosterone use among men: a systematic review and meta-analysis GC Alexander, G Iyer, E Lucas, D Lin, S Singh The American journal of medicine 130 (3), 293-305, 2017 | 128 | 2017 |
| The effect of vitamin D supplementation on glucose metabolism in type 2 diabetes mellitus: A systematic review and meta-analysis of intervention studies CJ Lee, G Iyer, Y Liu, RR Kalyani, CB Ligon, S Varma, N Mathioudakis Journal of Diabetes and its Complications 31 (7), 1115-1126, 2017 | 127 | 2017 |
| Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews O Onasanya, G Iyer, E Lucas, D Lin, S Singh, GC Alexander The Lancet Diabetes & Endocrinology 4 (11), 943-956, 2016 | 110 | 2016 |
| Antiretroviral drugs: critical issues and recent advances M Desai, G Iyer, RK Dikshit Indian journal of pharmacology 44 (3), 288-298, 2012 | 110 | 2012 |
| Prescribing pattern and appropriateness of drug treatment of diarrhoea in hospitalised children at a tertiary care hospital in India. JR Panchal, CK Desai, GS Iyer, PP Patel, RK Dikshit | 22 | 2013 |
| Association of type of oral anticoagulant dispensed with adverse clinical outcomes in patients extending anticoagulation therapy beyond 90 days after hospitalization for venous … A Pawar, JJ Gagne, C Gopalakrishnan, G Iyer, H Tesfaye, G Brill, K Chin, ... Jama 327 (11), 1051-1060, 2022 | 18 | 2022 |
| Trends in the use of oral anticoagulants for adults with venous thromboembolism in the US, 2010-2020 GS Iyer, H Tesfaye, NF Khan, H Zakoul, K Bykov JAMA Network Open 6 (3), e234059-e234059, 2023 | 14 | 2023 |
| Evaluation of impact of teaching clinical pharmacology and rational therapeutics to medical undergraduates and interns MK Desai, JR Panchal, S Shah, G Iyer International Journal of Applied and Basic Medical Research 6 (3), 205-210, 2016 | 14 | 2016 |
| An algorithm to identify generic drugs in the FDA adverse event reporting system G Iyer, SP Marimuthu, JB Segal, S Singh Drug safety 40, 799-808, 2017 | 10 | 2017 |
| An analysis of the pharmacological management of respiratory tract infections in pediatric in-patients at a tertiary care teaching hospital. GS Iyer, PP Patel, JR Panchal, RK Dikshit International Journal of Medicine & Public Health 3 (3), 2013 | 8 | 2013 |
| Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews. Lancet Diabetes Endocrinol. 2016; 4: 943–56 O Onasanya, G Iyer, E Lucas, D Lin, S Singh, GC Alexander Přejít k původnímu zdroji... Přejít na PubMed, 2018 | 6 | 2018 |
| Cardiovascular risks of exogenous testosterone use among men: a systematic review and meta-analysis GC Alexander, G Iyer, E Lucas, D Lin, S Singh Value in Health 19 (3), A43, 2016 | 5 | 2016 |
| Advances in antiretroviral drugs M Desai, G Iyer, RK Dikshit Indian J Pharmacol 44, 288-98, 2012 | 5 | 2012 |
| Patient-relevant outcomes associated with generic tamsulosin, levothyroxine and amphetamine in the FDA Adverse Event Reporting System: a pilot study SP Marimuthu, G Iyer, JB Segal, S Singh Journal of Comparative Effectiveness Research 6 (5), 437-447, 2017 | 4 | 2017 |
| Knowledge, attitude, and practice about diabetes and its treatment in patients attending the speciality clinic BB Benjamin, PP Patel, GS Iyer, A Gandhi, RK Dikshit Int Res J Pharm 8, 35-8, 2017 | 4 | 2017 |
| Cardiovascular risks associated with clarithromycin G Iyer, GC Alexander BMJ 352, 2016 | 4 | 2016 |
| Challenges to diagnosis and management of infections in older adults T Rowe, G Iyer New Directions in Geriatric Medicine: Concepts, Trends, and Evidence-Based …, 2016 | 4 | 2016 |
| Identification of generic drugs in the FDA adverse event reporting system GS Iyer, SP Marimuthu, JB Segal, S Singh PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 25, 406-407, 2016 | 2 | 2016 |
| The effectiveness and safety of extended anticoagulant treatment in patients with venous thromboembolism N Khan, G Iyer, H Tesfaye, G Brill, K Bykov PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 73-74, 2022 | | 2022 |
